| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |